Growth Metrics

RxSight (RXST) Assets Average (2021 - 2025)

RxSight (RXST) has disclosed Assets Average for 5 consecutive years, with $310.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 1.38% year-over-year to $310.2 million, compared with a TTM value of $310.2 million through Dec 2025, down 1.38%, and an annual FY2025 reading of $315.2 million, up 25.8% over the prior year.
  • Assets Average was $310.2 million for Q4 2025 at RxSight, roughly flat from $308.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $315.8 million in Q1 2025 and bottomed at $149.3 million in Q3 2021.
  • Average Assets Average over 5 years is $225.6 million, with a median of $193.4 million recorded in 2021.
  • The sharpest move saw Assets Average decreased 22.85% in 2022, then soared 72.7% in 2025.
  • Year by year, Assets Average stood at $198.2 million in 2021, then decreased by 22.85% to $152.9 million in 2022, then grew by 19.14% to $182.2 million in 2023, then soared by 72.62% to $314.5 million in 2024, then dropped by 1.38% to $310.2 million in 2025.
  • Business Quant data shows Assets Average for RXST at $310.2 million in Q4 2025, $308.8 million in Q3 2025, and $311.0 million in Q2 2025.